Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

10.9%

6 terminated/withdrawn out of 55 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

33%

18 trials in Phase 3/4

Results Transparency

11%

2 of 18 completed trials have results

Key Signals

8 recruiting2 with results

Enrollment Performance

Analytics

Phase 4

10(27.8%)

Phase 3

8(22.2%)

N/A

8(22.2%)

Phase 2

6(16.7%)

Phase 1

4(11.1%)

36Total

Phase 4(10)

Phase 3(8)

N/A(8)

Phase 2(6)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials

NCT05766046Not ApplicableActive Not Recruiting

Lung Cancer Prevention Screening Programme in Italy

Role: collaborator

NCT06871150Not ApplicableRecruiting

Three Different GHDT ( Goal Hemodynamic Directed Therapy) Strategies for Intraoperative Fluid Management Optimization During Major Abdominal Surgery: A Randomized Controlled Trial

Role: collaborator

NCT07408453Recruiting

Antenatal Stress and Infants In MAR

Role: collaborator

NCT06472063Recruiting

Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study

Role: collaborator

NCT06375915Phase 2Recruiting

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

Role: collaborator

NCT06358768Not Yet Recruiting

Post-Partum Haemorrhage (PPH) Improvement of Skills With Actor Simulations

Role: collaborator

NCT03131531Recruiting

Bergamo Lymphoid Cancer Registry

Role: lead

NCT06192524Unknown

OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry

Role: collaborator

NCT06163833Phase 2Recruiting

Mesenchymal Stromal Cells for Traumatic Brain Injury

Role: collaborator

NCT05448092Unknown

Registry for Evaluation of Lumbar Arthrodesis Sagittal alignmEnt

Role: collaborator

NCT04945603Recruiting

Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group

Role: collaborator

NCT02012153Phase 1Terminated

Mesenchymal Stromal Cells in Kidney Transplant Recipients

Role: collaborator

NCT04346589Not ApplicableTerminated

Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients

Role: lead

NCT04420000Not ApplicableCompleted

Effects of Mindfulness Therapy in Patients With Acromegaly and Cushing

Role: collaborator

NCT00704561Not ApplicableCompleted

Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography

Role: lead

NCT05341635Completed

FAst and SimplE COVID-19 Causing Virus SARS-CoV-2 Detection

Role: collaborator

NCT03821519Phase 1Unknown

Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant

Role: lead

NCT03823365Phase 1Unknown

Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia

Role: lead

NCT03813134Not ApplicableUnknown

Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Role: collaborator

NCT03380767Not ApplicableWithdrawn

Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy: a Pragmatic Randomized Clinical Trial.

Role: lead